What is Mogrify?
Mogrify is a pioneering biopharmaceutical company dedicated to revolutionizing the landscape of ex vivo cell therapies. The company is at the forefront of developing in vivo reprogramming therapies, a groundbreaking approach that promises to redefine treatment paradigms. By focusing on these advanced therapeutic modalities, Mogrify aims to address unmet medical needs and establish new standards of care in regenerative medicine and beyond. Their work is critical in the rapidly evolving field of biotechnology.
How much funding has Mogrify raised?
Mogrify has raised a total of $47.8M across 4 funding rounds:
Angel/Seed
$3.7M
Private Equity
$1.1M
Series A
$33M
Series A
$10M
Angel/Seed (2019): $3.7M with participation from 24Haymarket, Ahren, and Dr Disley
Private Equity (2020): $1.1M led by SBRI Healthcare
Series A (2021): $33M supported by Dr. Jonathan Milner, Parkwalk Advisors, Ahren Innovation Capital, Astellas Venture Management, University of Bristol Enterprise Fund III, Dr. Darrin Disley, and 24Haymarket
Series A (2023): $10M featuring Parkwalk Advisors, Astellas Venture Management, and Ahren Innovation Capital
Key Investors in Mogrify
Parkwalk Advisors
Parkwalk is a leading investor in university spinouts, focusing on deeptech innovations emerging from the UK's top universities. With over 15 years of experience, they bridge the gap between academic research and commercial success by providing funding, expertise, and networks to help these companies thrive. Their investment strategy spans the entire spinout lifecycle, supporting ventures in sectors such as AI, Quantum Computing, HealthTech, and CleanTech. Parkwalk offers tax-efficient investment opportunities for those looking to support groundbreaking science and technology.
Astellas Venture Management
vcfund.me specializes in providing templates for various types of formal communication, including email and complaint letters. Their resources cater to a diverse clientele such as students, parents, and consumers who need assistance in articulating their concerns or requests. The templates are designed to enhance clarity and professionalism in communication, addressing issues ranging from school bullying to food complaints. By offering structured examples, vcfund.me aims to empower individuals to effectively navigate challenging communication scenarios.
Ahren Innovation Capital
Ahren Innovation Capital is an investment institution focused on supporting transformational companies at the intersection of deep technology and deep science. With over $400 million in available capital, they partner with exceptional founders and teams at all stages, from pre-seed to pre-IPO, to create and grow innovative businesses. Their investment interests span four domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. Ahren emphasizes building strong relationships and trust, providing both patient and active capital to empower visionary entrepreneurs.
What's next for Mogrify?
With the recent influx of major strategic investment, Mogrify is poised for significant expansion and accelerated research and development. This capital infusion is anticipated to fuel the progression of their innovative cell therapy platforms, potentially leading to faster clinical translation and broader market penetration. The company's strategic focus on both ex vivo and in vivo reprogramming therapies positions it for sustained growth and leadership in the biopharmaceutical sector. Future developments will likely involve expanding their therapeutic pipeline and forging key partnerships.
See full Mogrify company page
